Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates. Selby LV, Clark E, Chen JL, Tinoco G, et al. J Surg Oncol 2024;130:579-585.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Selby LV, Clark E, Chen JL, Tinoco G, et al. Use of neoadjuvant paclitaxel in breast angiosarcoma-Impact on surgical resection and response rates. J Surg Oncol 2024;130:579-585.
PMID: 39016208